Skip to content

Clinical trials

Completed Thrombocythemia, Essential trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocythemia, Essential Status: Completed Clear all

131 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20007
20011
20028
20031
20044
200511
200610
20078
20087
20093
201010
20116
20126
20134
20148
20153
20162
20174
20183
20192
20202
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed131

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center12
National Cancer Institute (NCI)11
Shire8
Icahn School of Medicine at Mount Sinai4
AOP Orphan Pharmaceuticals AG3
Case Comprehensive Cancer Center3
Eli Lilly and Company3
European Organisation for Research and Treatment of Cancer - EORTC3
Mayo Clinic3
Memorial Sloan Kettering Cancer Center3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocythemia, Essential131
Polycythemia Vera103
Primary Myelofibrosis97
Myeloproliferative Disorders84
Precursor Cell Lymphoblastic Leukemia-Lymphoma57
Leukemia, Myeloid, Acute56
Leukemia, Myelomonocytic, Chronic56
Leukemia, Lymphocytic, Chronic, B-Cell54
Multiple Myeloma49
Burkitt Lymphoma48

Trials

Showing 1 to 25 of 131. Each trial links to its page on Pharma Observatory.

31 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.